Alzheimer's disease biomarker discovery using SOMAscan multiplexed protein technology
Open Access
- 28 April 2014
- journal article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 10 (6) , 724-734
Abstract
Blood proteins and their complexes have become the focus of a great deal of interest in the context of their potential as biomarkers of Alzheimer's disease (AD). We used a SOMAscan assay for quantifying 1001 proteins in blood samples from 331 AD, 211 controls, and 149 mild cognitive impaired (MCI) subjects. The strongest associations of protein levels with AD outcomes were prostate‐specific antigen complexed to α1‐antichymotrypsin (AD diagnosis), pancreatic prohormone (AD diagnosis, left entorhinal cortex atrophy, and left hippocampus atrophy), clusterin (rate of cognitive decline), and fetuin B (left entorhinal atrophy). Multivariate analysis found that a subset of 13 proteins predicted AD with an accuracy of area under the curve of 0.70. Our replication of previous findings provides further evidence that levels of these proteins in plasma are truly associated with AD. The newly identified proteins could be potential biomarkers and are worthy of further investigation.Keywords
Funding Information
- NIHR Newcastle Biomedical Research Centre
This publication has 52 references indexed in Scilit:
- Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer DiseaseArchives of Neurology, 2012
- Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive ImpairmentBrain Topography, 2012
- A Blood-Based Algorithm for the Detection of Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2011
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker DiscoveryPLOS ONE, 2010
- Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohortNeuroImage, 2010
- A Serum Protein–Based Algorithm for the Detection of Alzheimer DiseaseArchives of Neurology, 2010
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer DiseaseArchives of General Psychiatry, 2010
- Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic modelBMC Medical Informatics and Decision Making, 2010
- Relationships between biomarkers in aging and dementiaNeurology, 2009
- Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal FluidBiological Psychiatry, 2009